Abstracts

LOOP-MEDIATED ISOTHERMAL AMPLIFICATION ASSAY TO DIAGNOSE TUBERCULOSIS IN RURAL UGANDA

In resource-limited settings, smear microscopy for tuberculosis (TB) diagnosis lacks sensitivity especially in HIV co-infection, resulting in undiagnosed TB and high mortality. Various molecular tests have been developed to improve TB diagnosis. The loop-mediated isothermal amplification assay (TB-LAMP test) can be staged with minimal infrastructure and is rapid, low cost and detection is with the…

EXTRAPULMONARY TB AT ART PROGRAMS IN LOWER-INCOME COUNTRIES: DIAGNOSTICS AND OUTCOMES

Extrapulmonary tuberculosis (EPTB) is difficult to confirm bacteriologically and requires specific diagnostic capacities. We studied diagnostic modalities and clinical outcomes of EPTB compared to pulmonary tuberculosis (PTB) among HIV-positive adults. We collected patient data from HIV/TB co-infected adults (≥16 years) from antiretroviral (ART) programs participating in the IeDEA network in Africa, Asia/Pacific and Central/South America…

EFFECTS OF CALCIUM AND VITAMIN D SUPPLEMENTATION ON BONE HEALTH IN HIV-INFECTED YOUTH

Adverse bone health is an important complication in people living with HIV. Calcium and vitamin D (Ca/VitD) supplementation have demonstrated beneficial impacts on bone health. This study aimed to evaluate effects of Ca/VitD supplementation on bone metabolism and bone mineral density (BMD) in HIV-infected Thai youth. An ongoing, multicenter, 48-week, randomized, open-label trial has been…

RECENCY STAGING OF HIV INFECTIONS THROUGH ROUTINE DIAGNOSTIC TESTING

Assay based staging of HIV for recency of infection has multiple purposes: at the population level, it enables cross-sectional incidence estimation. At the individual level, at diagnosis (as available in some national programmes and being contemplated in other large scale systems) recent/non-recent infection classification helps guide psychosocial support strategies, contact tracing, or inclusion in clinical…

DEVELOPMENT OF A HIGH-THROUGHPUT MULTIPLEX ASSAY FOR MEASURING HIV INCIDENCE

In order to assess the impact of HIV prevention strategies, it is critical to measure the rate at which new HIV infections are occurring in populations. To achieve needed performance requirements (e.g., long ‘mean duration of recent infection’ [MDRI], low ‘false recent rate’ [FRR]), most programs currently use multi-assay algorithms including avidity-modified antibody and viral…

IDENTIFYING RECENT HIV INFECTIONS: AN INDIVIDUALIZED ASSESSMENT OF RISK

The accurate identification of recent HIV infection remains an important area of research to inform population-based HIV prevention and treatment intervention policies. Methods that use cross-sectional testing and biomarker information might be an alternative to longitudinal testing, as combinations of serological and molecular methods can potentially provide a means to identify recent HIV infections. The…